A detailed history of Jefferies Financial Group Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 10,000 shares of GKOS stock, worth $1.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,000
Previous 15,876 37.01%
Holding current value
$1.3 Million
Previous $1.5 Million 20.92%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$89.48 - $118.35 $525,784 - $695,424
-5,876 Reduced 37.01%
10,000 $1.18 Million
Q1 2024

May 13, 2024

BUY
$76.4 - $96.33 $762,166 - $960,988
9,976 Added 169.08%
15,876 $1.5 Million
Q4 2023

Feb 13, 2024

SELL
$59.53 - $85.11 $262,586 - $375,420
-4,411 Reduced 42.78%
5,900 $468,000
Q3 2023

Nov 14, 2023

BUY
$69.23 - $79.09 $713,830 - $815,496
10,311 New
10,311 $775,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.2B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.